? Cancer Research Training and Education Coordination (CRTEC) Education and training have been central to the mission of the Abramson Cancer Center (ACC) throughout its existence. The ACC Cancer Research Training and Education Coordination (CRTEC) component coordinates ACC cancer-related education, training, and career activities. In this role, CRTEC integrates these activities across the Penn campus, including the ACC, the Perelman School of Medicine (PSOM), and nine other Penn Schools that have activities with cancer education and training content. A prime focus of CRTEC is to drive and promote cancer education and training activities in the ACC and across the University of Pennsylvania with the goals of delivering cancer-related education to students, trainees, faculty, and other professionals and expanding and diversifying the cancer workforce through targeted education, training, and mentorship.
The Specific Aims of CRTEC are as follows:
Aim 1 : Coordinate cancer education, training, and career development activities across the ACC and Penn;
Aim 2 : Provide cancer research-related education, training, and mentorship to individuals ranging from high school and undergraduate students to cancer professionals, with an emphasis on ensuring a diverse and enduring pipeline of trainees and future cancer researchers;
and Aim 3 : Evaluate the quality and impact of ACC CRTEC activities to improve ACC education/training and to guide new CRTEC developments. CRTEC impacts students, trainees, and professionals with a goal to advance cancer research careers starting with entry-level professional training through faculty and cancer research leadership roles. CRTEC is led by an ACC Associate Director for Education and Training, senior support staff, and an Operations Committee. It interacts with the Programs, Shared Resources, and Community Outreach and Engagement. CRTEC impacts the ACC by (1) coordinating the already diverse, well-established, and extensive cancer-related education and training activities at the ACC and Penn; (2) improving access to cancer-related education for students, trainees, staff, and professionals; (3) sustaining cancer career development through integrated cancer-related training and mentoring for faculty, trainees, and staff; and (4) enhancing diversity at all levels of education and training. CRTEC leverages formidable strengths at ACC and Penn in cancer education and training that include a compact, accessible, and highly integrated campus with extraordinary depth in all disciplines relevant to cancer research; longstanding cancer-focused education in the ACC, PSOM and other Schools; a uniquely large and diverse portfolio of GME and biomedical postdoctoral training programs, many with decades of NCI and other funding; extensive ACC-directed professional education; and expertise and national leadership in basic, translational, clinical, and population-based cancer research. CRTEC provides ACC members with a central point of contact for innovations in cancer-related education and training.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Hinderer, Christian; Katz, Nathan; Buza, Elizabeth L et al. (2018) Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hum Gene Ther 29:285-298
Li, Jinyang; Byrne, Katelyn T; Yan, Fangxue et al. (2018) Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity 49:178-193.e7
Raghunathan, Nirupa Jaya; Korenstein, Deborah; Li, Qing S et al. (2018) Determinants of mobile technology use and smartphone application interest in cancer patients. Cancer Med 7:5812-5819
Hordeaux, Juliette; Wang, Qiang; Katz, Nathan et al. (2018) The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice. Mol Ther 26:664-668
Echevarría-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10:
Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney et al. (2018) Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH. Cell Syst 6:171-179.e5
Vonderheide, Robert H (2018) The Immune Revolution: A Case for Priming, Not Checkpoint. Cancer Cell 33:563-569
Romero, Sally A D; Jones, Lee; Bauml, Joshua M et al. (2018) The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer 26:3423-3430
Safo, Sandra E; Li, Shuzhao; Long, Qi (2018) Integrative analysis of transcriptomic and metabolomic data via sparse canonical correlation analysis with incorporation of biological information. Biometrics 74:300-312
Kall, Stefanie L; Delikatny, Edward J; Lavie, Arnon (2018) Identification of a Unique Inhibitor-Binding Site on Choline Kinase ?. Biochemistry 57:1316-1325

Showing the most recent 10 out of 1047 publications